UHS Stock Chart & Stats
€135.00
€4.00(3.05%)
At close: 4:00 PM EDT
€135.00
€4.00(3.05%)
Day’s Range― - ―
52-Week Range€121.00 - €210.00
Previous CloseN/A
Volume20.00
Average Volume (3M)16.00
Market Cap
€8.78B
Enterprise Value€14.17K
Total Cash (Recent Filing)€119.03M
Total Debt (Recent Filing)€5.13B
Price to Earnings (P/E)6.7
Beta0.20
Next Earnings
Oct 28, 2026EPS Estimate
4.71Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)24.14
Shares Outstanding53,287,605
10 Day Avg. Volume16
30 Day Avg. Volume16
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)1.91
Price to Sales (P/S)0.80
P/FCF Ratio16.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€170.69Price Target Upside26.43% Upside
Rating ConsensusHold
Number of Analyst Covering13
EPS Forecast (FY)19.97
Revenue Forecast (FY)€16.24B
Bulls Say, Bears Say
Bulls Say
Improved Margins And ProfitabilityUHS has sustained margin improvement with TTM net margin around 8.6% and EBITDA margin ~15.8%, reflecting operational efficiency across acute and behavioral segments. Strong profitability supports reinvestment in capacity, funds discretionary buybacks, and underpins durable cash earnings even if top-line growth moderates.
Behavioral Health Expansion & Talkspace DealAcquiring Talkspace creates an integrated, end-to-end behavioral health platform by adding virtual outpatient scale. This structural move broadens the addressable market, diversifies revenue mix toward higher-margin outpatient care, and leverages secular demand for virtual behavioral services over the medium term.
Manageable Leverage And Capital FlexibilityLeverage metrics and available liquidity provide financial flexibility: net leverage near 1.8x, a $1.27B revolver and substantial repurchase authority. That balance-sheet headroom supports de novo openings, targeted M&A/virtual investments, and opportunistic buybacks without forcing distressed refinancing in normal cycles.
Bears Say
Weak Cash Conversion And Operating Cash Flow VolatilityA sharp Q2 drop in operating cash flow highlights volatile cash conversion: TTM free cash flow is materially below net income and OCF swings reflect working-capital, supplemental timing and startup drains. Persistent conversion volatility can constrain capital allocation, increase reliance on short-term facilities, and pressure FCF-driven initiatives.
Rising Liability Reserves And Professional FeesHigher liability reserves and an elevated full-year liability outlook create structural margin pressure, while professional fees are cited as rising in the high-single-digit range. These recurring cost trends erode hospital margins long term and increase per-unit cost to serve, making margin maintenance more challenging.
De Novo Ramp Delays And Reimbursement Loss At FacilitySlower-than-expected de novo ramps and a recertifying behavioral facility losing reimbursement create persistent startup losses. Reduced de novo tailwinds and ongoing per-facility operating losses can depress near-term EBITDA and prolong the timeline to breakeven for new capacity, increasing execution risk for growth initiatives.
Universal Health News
UHS FAQ
What was Universal Health Services’s price range in the past 12 months?
Universal Health Services lowest stock price was €121.00 and its highest was €210.00 in the past 12 months.
What is Universal Health Services’s market cap?
Universal Health Services’s market cap is €8.78B.
When is Universal Health Services’s upcoming earnings report date?
Universal Health Services’s upcoming earnings report date is Oct 28, 2026 which is in 90 days.
How were Universal Health Services’s earnings last quarter?
Universal Health Services released its earnings results on Jul 27, 2026. The company reported €5.221 earnings per share for the quarter, beating the consensus estimate of €5.186 by €0.035.
Is Universal Health Services overvalued?
According to Wall Street analysts Universal Health Services’s price is currently Undervalued.
Does Universal Health Services pay dividends?
Universal Health Services does not currently pay dividends.
What is Universal Health Services’s EPS estimate?
Universal Health Services’s EPS estimate is 4.71.
How many shares outstanding does Universal Health Services have?
Universal Health Services has 53,287,605 shares outstanding.
What happened to Universal Health Services’s price movement after its last earnings report?
Universal Health Services reported an EPS of €5.221 in its last earnings report, beating expectations of €5.186. Following the earnings report the stock price went down -2.206%.
Which hedge fund is a major shareholder of Universal Health Services?
Currently, no hedge funds are holding shares in DE:UHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Universal Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€170.69 (26.43% Upside)
€170.69 (26.43% Upside)
Blogger Sentiment
Bullish
DE:UHS Sentiment 71%
Sector Average ―
Sector Average ―
News Sentiment
Bearish
Bullish news 38%
Bearish news 62%
Bearish news 62%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.61%
12-Months-Change
Fundamentals
Return on Equity
0.47%
Trailing 12-Months
Asset Growth
6.34%
Trailing 12-Months
Company Description
Universal Health Services
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
UHS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixture of solid operational progress and clear strategic initiatives (EPS and EBITDA growth, new capacity additions, Joint Commission accreditation, Talkspace acquisition, active share repurchases, and continued rate and revenue per unit growth) alongside multiple material near-term headwinds (out-of-period supplemental benefits masking underlying shortfalls, higher liability reserves, de novo ramp delays, a recertifying Texas behavioral facility with ongoing losses, a steep drop in operating cash flow, and a trimmed EBITDA outlook). Management retained a constructive long-term view and updated guidance still shows growth, but several one-time and structural challenges are weighing on near-term results and cash flow.View all DE:UHS earnings summariesUHS Net revenue Breakdown
9.61% Medicare
10.85% Managed Medicare
12.97% Medicaid
13.27% Managed Medicaid
25.89% Managed Care (HMO and PPOs)
5.07% UK Revenue
6.41% Other patient revenue and adjustments, net
7.08% Other non-patient revenue

UHS Stock 12 Month Forecast
Average Price Target
€170.69
▲(26.43% Upside)
Technical Analysis
Acadia Healthcare
―
Community Health
―
HCA Healthcare
―
Encompass Health
―
Tenet Healthcare
―










